Switzerland· 67306001
Elmiron
A pentosan polysulfate sodium product containing heparinoidum (natrii pentosani polysulfas), registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 10 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Pentosan polysulfate sodium is registered in 10 of 19 countries.
Countries holding a registration under ATC G04BX15 (pentosan polysulfate sodium), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 7 of them publish a price we can compare per daily dose
Pentosan polysulfate sodium · ATC G04BX15
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of pentosan polysulfate sodium costs, country by country.
Normalised to the WHO defined daily dose (0.3 g), so markets compare like for like.
- Switzerland: $19.03 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Pentosan polysulfate sodium · price per daily dose (0.3 g)
USD · FX 28 Sept 2026
- CH Switzerland$19.03
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Active substance
- heparinoidum (natrii pentosani polysulfas)
- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- G04BX15
- ATC class
- Pentosan polysulfate sodium
- Defined daily dose
- 0.3 g, O
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680673060018Ds 90 StkCHF 473.55
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
74 interactions on record for pentosan polysulfate sodium.
Graded by severity as the source publishes them — 74 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pentosan polysulfate sodium · interactions on record
74 records
- 74 moderate
Most severe, free to view
- DicoumarolB01AA01moderate
- WarfarinB01AA03moderate
- HeparinB01AB01moderate
- Antithrombin IIIB01AB02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Pentosan polysulfate sodium in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cedff57a-f408-443f-a01e-93632478bccd GET /v1/drugs/cedff57a-f408-443f-a01e-93632478bccd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "natrii pentosanpolysulfas 100 mg",
"valid_from": "2026-04-01",
"limitations": "[{\"description\":\"Nach vorgängiger Kostengutsprache zur symptomatischen Behandlung von persistierenden oder rezidivierenden Schmerzen / unangenehmes Gefühl/Druckgefühl, welche als mit der Blase zusammenhängend empfunden werden und begleitet von Symptomen des unteren Harntraktes (Pollakisurie\\n(10x/Tag) oder Drang bedingt durch Schmerzen, Druckgefühle oder Missempfinden ohne Angst vor Inkontinenz) beim Syndrom der schmerzhaften Harnblase (BPS) bei Erwachsenen mit einer Dauer von mehr als 3 Monaten, sofern:<br>\\n- Die Einleitung der Behandlung nach Ausschluss eines HWI oder anderer erkennbarer Ursachen durch einen Facharzt der Urologie oder Gynäkologie mit Schwerpunkt Urogynäkologie erfolgt<br>\\n- Hunner Läsionen und/oder Glomerulationen zystoskopisch nachgewiesen wurden<br>\\n- die Erkrankung nicht auf orale Therapien wie klassische und neuropathische Analgetika, Anticholinergika, Antihistaminika und klassische nicht-medikamentöse Ansätze angesprochen hat oder diese nach Ansicht des behandelnden Facharztes nicht indiziert sind<br>\\n- keine gleichzeitige Behandlung mit Blaseninstillationen stattfindet.<br>\\nIst nach 6 Monaten Behandlung keine Besserung ersichtlich, soll auf eine andere geeignetere Therapie umgestellt werden. Bei Ansprechen soll die Behandlung alle 3-6 Monate neu evaluiert werden.<br>\\n<br>\",\"costApproval\":null,\"indication\":\"20980.01\\t\",\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2026-04-01\",\"validTo\":\"2029-03-31\"}]",
"galenic_form": "Kaps 100 mg",
"therapeutic_area": null,
"sl_inclusion_date": "2022-12-01",
"self_retention_pct": 10
}See everything about pentosan polysulfate sodium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.